https://www.renbio.com/news_and_events/renbios-rachel-liberatore-to-present-at-vaccines-summit-2023/

Renbio

DNA Therapeutics - Next-generation medicines

Our name speaks for us. Did you know that the Chinese character “ren” means “people” and “humanity”?

RenBio was founded on the principle that the remarkable medical benefits of antibody therapeutics should be a right and be available to everyone who needs it.

Our Mission

Our Mission

Our mission is clear: we want to advance first-in-class and best-in-class DNA therapeutic technologies to humans.

Our Vision

Our Vision

We aim to enhance the field of antibodies and therapeutic proteins. We believe this is essential for creating a better world by reducing the impact of diseases worldwide.

Our Goals

Our Goals

Our goals are achievable as we strive for them daily. Nonetheless, they remain audacious. Firstly, we want to deliver antiviral antibodies to prevent the spread of infectious diseases. No less important, the improvement of the dosing regimen and effectiveness of therapeutic proteins is also on our list.

Our Values

Excellence on antibody therapeutics
Curiosity for "bioblueprints"
Thoughtful Action on next-generation medicines
Collective Wisdom for disease-fighting therapeutics
Optimism on a healthier world

Make Your Own Technology

RenBio’s Make Your Own Technology (MYO) delivers therapeutic “bioblueprints” through modified injections.

Muscle cells decode these blueprints to create an antibody factory that will produce disease-fighting treatments within the patient’s body.

We’re discussing DNA molecules here.

Learn more about MYO Technology™
the representation of an antibody
the representation of an antibody
the representation of an antibody
the representation of an antibody

Antibody and Protein Therapeutics, Reimagined

Antibodies and proteins therapeutics have significant potential in improving human health. However, challenges in administration, efficacy, duration, and cost limit their use. We have reimagined how we can help in this field, producing and delivering antibody and protein therapeutics to overcome these obstacles.

Our delivery platform uses the body’s ability to create specific antibodies or therapeutic proteins by giving it the right genetic instructions. These instructions, encoded in DNA, are biological blueprints, or “bioblueprints”.

Applications for MYO Technology
the representation of a science team on a meeting

A Dedicated Team

RenBio was co-founded by Drs. David Ho and Yaoxing Huang, visionary scientists and part of the Aaron Diamond AIDS Research Center in New York City.

Since 2016, our team has grown quickly and now includes experts in biology and engineering, with knowledge in various areas.

We use our knowledge and skills to create a technology. This technology can make antibodies and proteins.

We use these antibodies and proteins to prevent and treat various diseases. Our dedicated team is always working on the next-generation medicines.

Meet the Team
Darpa U.S. Defense Advanced Reserach Project Agency
Ruentex
TaiMed Biologics Logo
Bill & Melinda Gates foundation Logo
Endless Forintier Labs
Columbia University in the City of New York
Chenco Holdings
Astra Zeneca
With Public Support and in Partnership with
New York State of Opportunity - Empire State Development